Emergency Use Authorization Requirements May Offer FDA Better Window Into Medication Errors

 
• By Sarah Karlin-Smith
  
Regeneron COVID-19 antibodies and Moderna COVID-19 vaccine
Similar packaging lead to mix-ups of Regeneron’s COVID-19 antibodies (left) and Moderna’s COVID-19 vaccine. • Source: FDA
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet